Association between direct measurement of active serum calcium and risk of type 2 diabetes mellitus: a prospective study Zaccardi (1) . Numerous recent studies have highlighted the complexity of its pathophysiology, including abnormal gut/β-cell cross-talk, insufficient insulin secretion, and a reduced insulin action in peripheral tissues (2) .
Calcium plays an active role in both insulin secretion and its peripheral effects.
Glucose-dependent insulin exocytosis is a calcium-regulated process, being dependent upon β-cell intracellular calcium concentration (3) . Calcium is an established regulator of GLUT4 expression, a passive transporter essential for peripheral glucose uptake (4) . As a consequence, abnormalities in calcium homeostasis could potentially affect glucose metabolism and contribute to the development of T2DM (5) .
A possible association between calcium and T2DM risk has been explored in nutritional epidemiology studies: the available evidence, though, is limited because most studies are cross-sectional and did not adjust for important confounders (6) . Similarly, crosssectional and case-control studies investigating the relationship between calcium homeostasis and glucose metabolism have reported conflicting results (7) (8) (9) (10) (11) (12) (13) (14) (15) ; however, only a few studies have prospectively evaluated the association between serum calcium and risk of incident T2DM, suggesting that higher levels of serum calcium predict an increased risk of T2DM (16) (17) (18) . These studies have relied either on total serum calcium or the indirect, albumincorrected estimate of serum calcium: these measurements, however, only approximate the levels biological-active serum calcium (iCa) (19) . Interestingly, a previous case-control study did not find an association between directly measured iCa and prevalent diabetes (11) ;
similarly, in another small study, no association was found between direct iCa measurement and indices of diabetes control (15) .
To our knowledge, the relationship between directly measured iCa and the risk of incident T2DM has not been investigated in a prospective study setting. Thus, our aim was to evaluate the risk of T2DM in a population-based study using direct measurement of iCa levels.
This study was performed following the STROBE guidelines for observational studies (20).
Study population
The Kuopio Ischaemic Heart Disease risk factor study was designed to investigate risk predictors for atherosclerotic cardiovascular outcomes in a population-based sample of men from Eastern Finland. The subjects were a randomly selected sample of men 42 to 60 years of age resident in the town of Kuopio and its surrounding rural communities obtained from the national population register (21); baseline examinations were conducted between March 1984 and December 1989.
Of the 3433 invited, 2682 (78.1%) participated. In this study, participants were excluded if they were diagnosed with diabetes at baseline (n=162), defined as either having regular treatment with an oral hypoglycemic agent, insulin therapy, or having treatment only with diet while also having a fasting plasma glucose level of at least 7.0 mmol/L. We further excluded those subjects with missing baseline information on calcium (n=170). Therefore, data on 2350 participants were available for the analyses. Incident case of T2DM was defined as a self-reported physician-set diagnosis and/or fasting plasma glucose ≥7.0 mmol/L or 2-h oral glucose tolerance test plasma glucose ≥11.1 mmol/L at re-examination rounds 4, 11, and 20 years after baseline, and by record linkage to the national hospital discharge registry and to the Social Insurance Institution of Finland register for reimbursement of medicine expenses.
Assessment of risk factors
Prior to attendance at the baseline appointment, participants were instructed to abstain from drinking alcohol for a minimum of 3 days and from smoking for at least 12 hours.
Fasting blood samples were taken following a 30-minute rest period in the supine position and collected using vacuum tubes (Terumo Venoject; Terumo, Tokyo, Japan).
The resting blood pressure was measured with a random-zero sphygmomanometer (Hawksley, Lancing England) by two trained nurses. A total of six measurements (3 supine, 1 standing, and 2 sitting) were taken following a 5 minute supine rest and blood pressure was taken as the mean of all six measurements. Baseline medical history, smoking habits, years of education, family history of T2DM (defined as positive if a first-degree relative of the subject had T2DM history), and drug therapy were assessed by self-administered questionnaires. The diagnosis of chronic diseases was checked during a medical examination by the internist.
Detailed descriptions on physical activity estimation have been published previously (22) .
Body mass index (BMI) was computed as the ratio of weight in kilograms to the square of height in meters. All analyses were performed with Stata 13 (Stata Corp, College Station, TX, USA), and two-sided P-value < 0.05 was considered statistically significant.
RESULTS

Baseline characteristics and numbers of outcome events during follow-up
At baseline, mean (SD) age, BMI and iCa were 53 (5) Table 1 and Supplemental Table S1 , respectively. Levels of cardiometabolic risk factors (i.e., BMI, triglycerides, FPG, HOMA-IR) were higher in subjects who had developed T2DM during follow-up as compared to subjects who had not (Table 1) . 
Calcium as risk factor for incident type 2 diabetes mellitus
The relationship between baseline calcium levels and incident T2DM, progressively adjusted for potential confounders, is shown in Figure 1 (HRs are reported in Supplemental Table S2 ). In multivariable analysis adjusted for age, BMI, SBP, serum HDL-cholesterol, and family history of T2DM (model 1), we did not find an association between iCa and risk of T2DM: compared to the first quartile of iCa, the HRs for the second, third, and fourth quartiles were 0.84 (95% confidence interval: 0.59-1.18), 0.77 (0.52-1.14), and 0.98 (0.69-1.39), respectively (p for trend 0.538; Figure 1 and Supplemental Table S2 ). The respective 
DISCUSSION
Our results indicate that, in this cohort of middle-age Finnish men, direct measurement of active, ionized serum calcium is not associated with incident T2DM.
T2DM is a major cause of morbidity and mortality in the developed and developing world (25). Although much progress has been made in describing its physiopathology, there is a growing interest in the identification of new biomarkers to help clarify its aetiology or define subjects at higher risk of developing T2DM. The relationship between calcium and glucose homeostasis has long been recognized, with case-control studies assessing calcium fractions dating back to 1960s (26) . In parallel with observational work, experimental studies have described the role of calcium at the cellular and molecular level, clarifying fundamental second messenger functions in insulin secretion (3) and action (4, 27) .
Previous non-prospective observational studies have reported conflicting results about calcium levels (plasma, total serum, or albumin-corrected serum concentrations) and glucose homeostasis. In T2DM subjects, calcium levels have been shown to be higher (10, 13) and associated with fasting glucose or insulin resistance (8, 9, 12) ; conversely, other studies have reported no relationship with markers of glucose control (15) , insulin resistance (7), or insulin secretion (7, 9).
To our knowledge, only three studies have prospectively assessed the relationship between incident diabetes and calcium concentrations. The characteristics and a graphical summary of the results are reported in Supplemental Table S3 and Supplemental Figure S1 .
A large Norwegian study has assessed the association between non-fasting total serum calcium and risk of T2DM, cancer, and cardiovascular disease, showing a positive relationship with T2DM (16). However, this study has also shown no relationship between two single nucleotide polymorphisms associated with calcium concentration (rs1801725 and rs17251221) and risk of diabetes. More recently, two other smaller studies have investigated the link between fasting albumin-corrected serum calcium and incident T2DM, reporting positive associations (17, 18) . Of note, in both studies the Authors acknowledged as a major limitation the unavailability of direct measurement of iCa.
Direct measurement of active, ionized calcium is regarded as the gold standard of calcium measurement (19, 23, 28) . In normal conditions, about 50% of total serum calcium is present in iCa form, 35-40% is bound to negatively charged amino acid residues of proteins, and the remaining 10-15% is linked to small organic molecules (i.e., bicarbonate, citrate, sulfate, phosphate, lactate) to form complexes (23); therefore, conditions modifying one or more of these compounds could potentially result in changes of calcium fractions. In particular, alterations in albumin concentration, blood pH, use of drugs, or fatty acids bound to albumin change the ratio between total and iCa (19) . As the primary, most abundant negatively charged serum protein is albumin, a common equation is used to estimate the "albumin-adjusted" total calcium. This equation is derived from healthy volunteers, is valid only for specific combinations of total calcium and albumin assays within given reference intervals, and assumes a constant binding capacity of albumin (1g/dL albumin binds approximately 0.8 mg/dL calcium) (19, 23) . In subjects with T2DM there are many factors potentially modifying calcium fractions. In particular, high levels of circulating free fatty acids are known to alter calcium-albumin binding (29) and are also associated with incident risk of T2DM (30) . In this situation total or albumin-corrected estimation of serum calcium can be biased (11) (Supplemental Figure S2) . Similarly, higher levels of plasma lactate are associated with incident T2DM (31) and could modify calcium fractions (28) . Lastly, it is worth noting that adjustment for albumin concentration has been proposed for another biomarker associated with incident T2DM (fructosamine) (32, 33) , although it is still unclear the appropriateness of such adjustment given (34) .
Interestingly, our results are in line with a previous study showing no difference in direct iCa measurement comparing subjects with and without diabetes (11); notably, the Authors speculated that 'correction' of total calcium for serum albumin would not be appropriate because of an increased serum free fatty acids concentrations. Similarly, in another study, direct measurement of iCa was not associated with indices of diabetes control (15) . Notwithstanding the different exposure assessment, our results could be related to heterogeneous characteristics between populations (i.e., age, sex, race, or genetic background); or due to the ascertainment of outcomes; or associated to statistical planning and analysis; or a combination of all these. Notably, inherited characteristics, along with environmental factors, could explain the low values of iCa in our population. In fact, at high latitudes cutaneous synthesis of vitamin D is reduced, thus potentially resulting in low calcium levels (35) .
We should acknowledge some limitations and strengths of this study. First, a generalisation of our findings is defined by the study population, consisting of middle-age Finnish men only: these findings need to be confirmed in other ethnic groups and in females.
Second, we could not correct for a possible regression dilution bias (36), as we had only baseline assessment of iCa values. Nonetheless, for covariates with available repeated measurements, we have observed a rather stable "phenotype" (33) . Third, our study did not collect information about parathyroid hormone (PTH) and vitamin D for all participants; therefore, it was not possible to adjust for these variables or to exclude subjects at high risk of primary or secondary hyperparathyroidism, also implicated with glucose metabolism (5, 37).
However, adjustment for PTH (or vitamin D) requires that such a variable is associated with T2DM independent of iCa (38) , an assumption that needs to be verified. Fourth, as pH influences direct iCa measurement, it could be considered a confounder; this hypothesis could not be tested in our analysis, lacking baseline pH data. Yet, up to our knowledge, no available evidence suggests a relationship between pH and T2DM. Whether pH is a confounding factor, however, should be verified in future studies. On the other hand, strengths of this study include the rigorous measurement of baseline risk factors and assessment of T2DM, the large and homogeneous community-based sample, and the longterm follow-up.
In conclusion, in our cohort of middle-age Finnish men, direct measurement of iCa levels were not associated with incident T2DM risk. Further studies are needed to confirm our findings and elucidate the relationship between calcium and glucose metabolism. FZ had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
ETHICS
The study was approved by the Research Ethics Committee of the University of Eastern
Finland. Each participant gave written informed consent.
CONFLICT OF INTEREST
KK has acted as a consultant and speaker for Novartis, Novo Nordisk, Sanofi-Aventis, Lilly 
Supplemental Data
Association between direct measurement of active serum calcium and risk of type 2 diabetes mellitus: a prospective study Zaccardi Table S1 : Unadjusted correlation coefficients (r) between active serum calcium and other baseline covariates. 
